New dimension of glucocorticoids in cancer treatment

Steroids

Volumn 111, Issue , 2016, Pages 84-88

  Lin, Kai Ti ^a   Wang, Lu Hai ^a  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Glucocorticoid receptor; Glucocorticoids; Inflammation; Metastasis; microRNA; Tumor

Indexed keywords

GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; MICRORNA; ANTIINFLAMMATORY AGENT;

CANCER GROWTH; CANCER THERAPY; CYTOLOGY; HUMAN; INFLAMMATION; METASTASIS; NEOPLASM; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; DRUG EFFECTS; IMMUNOLOGY; METABOLISM; NEOPLASMS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; GLUCOCORTICOIDS; HUMANS; NEOPLASMS; RECEPTORS, GLUCOCORTICOID; SIGNAL TRANSDUCTION;

EID: 84959898461     PISSN: 0039128X     EISSN: 18785867     Source Type: Journal    
DOI: 10.1016/j.steroids.2016.02.019     Document Type: Review

References (64)

1. M. Kadmiel, and J.A. Cidlowski Glucocorticoid receptor signaling in health and disease Trends Pharmacol. Sci. 34 2013 518 530
2. O.J. Schoneveld, I.C. Gaemers, and W.H. Lamers Mechanisms of glucocorticoid signalling Biochim. Biophys. Acta 1680 2004 114 128
3. R. Kumar, and E.B. Thompson Gene regulation by the glucocorticoid receptor: structure:function relationship J. Steroid Biochem. Mol. Biol. 94 2005 383 394
4. W.B. Pratt, and D.O. Toft Steroid receptor interactions with heat shock protein and immunophilin chaperones Endocr. Rev. 18 1997 306 360
5. N.D. Freedman, and K.R. Yamamoto Importin 7 and importin alpha/importin beta are nuclear import receptors for the glucocorticoid receptor Mol. Biol. Cell 15 2004 2276 2286
6. M. Lowenberg, C. Stahn, D.W. Hommes, and F. Buttgereit Novel insights into mechanisms of glucocorticoid action and the development of new glucocorticoid receptor ligands Steroids 73 2008 1025 1029
7. I.H. Song, and F. Buttgereit Non-genomic glucocorticoid effects to provide the basis for new drug developments Mol. Cell. Endocrinol. 246 2006 142 146
8. A. Bruna, M. Nicolas, A. Munoz, J.M. Kyriakis, and C. Caelles Glucocorticoid receptor-JNK interaction mediates inhibition of the JNK pathway by glucocorticoids EMBO J. 22 2003 6035 6044
9. J.D. Croxtall, Q. Choudhury, and R.J. Flower Glucocorticoids act within minutes to inhibit recruitment of signalling factors to activated EGF receptors through a receptor-dependent, transcription-independent mechanism Br. J. Pharmacol. 130 2000 289 298
10. M. Gutierrez-Mecinas, A.F. Trollope, A. Collins, H. Morfett, S.A. Hesketh, F. Kersante, and et al. Long-lasting behavioral responses to stress involve a direct interaction of glucocorticoid receptors with ERK1/2-MSK1-Elk-1 signaling Proc. Natl. Acad. Sci. U.S.A. 108 2011 13806 13811
11. L. Xiao, C. Feng, and Y. Chen Glucocorticoid rapidly enhances NMDA-evoked neurotoxicity by attenuating the NR2A-containing NMDA receptor-mediated ERK1/2 activation Mol. Endocrinol. 24 2010 497 510
12. H. Leis, A. Page, A. Ramirez, A. Bravo, C. Segrelles, J. Paramio, and et al. Glucocorticoid receptor counteracts tumorigenic activity of Akt in skin through interference with the phosphatidylinositol 3-kinase signaling pathway Mol. Endocrinol. 18 2004 303 311
13. E. Solito, A. Mulla, J.F. Morris, H.C. Christian, R.J. Flower, and J.C. Buckingham Dexamethasone induces rapid serine-phosphorylation and membrane translocation of annexin 1 in a human folliculostellate cell line via a novel nongenomic mechanism involving the glucocorticoid receptor, protein kinase C, phosphatidylinositol 3-kinase, and mitogen-activated protein kinase Endocrinology 144 2003 1164 1174
14. F. Buttgereit, and A. Scheffold Rapid glucocorticoid effects on immune cells Steroids 67 2002 529 534
15. F. Buttgereit, R.H. Straub, M. Wehling, and G.R. Burmester Glucocorticoids in the treatment of rheumatic diseases: an update on the mechanisms of action Arthritis Rheum. 50 2004 3408 3417
16. P.S. Hench, C.H. Slocumb, and et al. The effects of the adrenal cortical hormone 17-hydroxy-11-dehydrocorticosterone (Compound E) on the acute phase of rheumatic fever; preliminary report Proc. Staff Meet. Mayo Clin. 24 1949 277 297
17. A.R. Clark, and M.G. Belvisi Maps and legends: the quest for dissociated ligands of the glucocorticoid receptor Pharmacol. Ther. 134 2012 54 67
18. U. Baschant, and J. Tuckermann The role of the glucocorticoid receptor in inflammation and immunity J. Steroid Biochem. Mol. Biol. 120 2010 69 75
19. M. Perretti, and A. Ahluwalia The microcirculation and inflammation: site of action for glucocorticoids Microcirculation 7 2000 147 161
20. K. De Bosscher, W. Vanden Berghe, and G. Haegeman The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression Endocr. Rev. 24 2003 488 522
21. A.C. Liberman, J. Druker, M.J. Perone, and E. Arzt Glucocorticoids in the regulation of transcription factors that control cytokine synthesis Cytokine Growth Factor Rev. 18 2007 45 56
22. S.M. Abraham, and A.R. Clark Dual-specificity phosphatase 1: a critical regulator of innate immune responses Biochem. Soc. Trans. 34 2006 1018 1023
23. S.M. Abraham, T. Lawrence, A. Kleiman, P. Warden, M. Medghalchi, J. Tuckermann, and et al. Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1 J. Exp. Med. 203 2006 1883 1889
24. S. Bhattacharyya, D.E. Brown, J.A. Brewer, S.K. Vogt, and L.J. Muglia Macrophage glucocorticoid receptors regulate Toll-like receptor 4-mediated inflammatory responses by selective inhibition of p38 MAP kinase Blood 109 2007 4313 4319
25. D.W. Kufe, J.F. Holland, and E. Frei American Cancer Society Cancer Medicine 6 6th ed. 2003 BC Decker Hamilton, Ont.; Lewiston, NY
26. Z. Wang, M.H. Malone, H. He, K.S. McColl, and C.W. Distelhorst Microarray analysis uncovers the induction of the proapoptotic BH3-only protein Bim in multiple models of glucocorticoid-induced apoptosis J. Biol. Chem. 278 2003 23861 23867
27. S. Greenstein, K. Ghias, N.L. Krett, and S.T. Rosen Mechanisms of glucocorticoid-mediated apoptosis in hematological malignancies Clin. Cancer Res. 8 2002 1681 1694
28. D. Walsh, and J. Avashia Glucocorticoids in clinical oncology Clevel. Clin. J. Med. 59 1992 505 515
29. B.D. Keith Systematic review of the clinical effect of glucocorticoids on nonhematologic malignancy BMC Cancer 8 2008 84
30. A. Gennari, B. Salvadori, A. Tognoni, and P.F. Conte Rapid intravenous premedication with dexamethasone prevents hypersensitivity reactions to paclitaxel Ann. Oncol. 7 1996 978 979
31. M. Zimmermann, and P. Drings Guidelines for therapy of pain in cancer patients Recent results in cancer research Fortschritte der Krebsforschung Progres dans les recherches sur le cancer 89 1984 1 12
32. S. Karmakar, Y. Jin, and A.K. Nagaich Interaction of glucocorticoid receptor (GR) with estrogen receptor (ER) alpha and activator protein 1 (AP1) in dexamethasone-mediated interference of ERalpha activity J. Biol. Chem. 288 2013 24020 24034
33. B. Sahu, M. Laakso, P. Pihlajamaa, K. Ovaska, I. Sinielnikov, S. Hautaniemi, and et al. FoxA1 specifies unique androgen and glucocorticoid receptor binding events in prostate cancer cells Cancer Res. 73 2013 1570 1580
34. N.M. Rubenstein, Y. Guan, P.L. Woo, and G.L. Firestone Glucocorticoid down-regulation of RhoA is required for the steroid-induced organization of the junctional complex and tight junction formation in rat mammary epithelial tumor cells J. Biol. Chem. 278 2003 10353 10360
35. Y. Zheng, K. Izumi, Y. Li, H. Ishiguro, and H. Miyamoto Contrary regulation of bladder cancer cell proliferation and invasion by dexamethasone-mediated glucocorticoid receptor signals Mol. Cancer Ther. 11 2012 2621 2632
36. M.E. Law, P.E. Corsino, S.C. Jahn, B.J. Davis, S. Chen, B. Patel, and et al. Glucocorticoids and histone deacetylase inhibitors cooperate to block the invasiveness of basal-like breast cancer cells through novel mechanisms Oncogene 32 2013 1316 1329
37. J. Folkman, R. Langer, R.J. Linhardt, C. Haudenschild, and S. Taylor Angiogenesis inhibition and tumor regression caused by heparin or a heparin fragment in the presence of cortisone Science 221 1983 719 725
38. A. Yano, Y. Fujii, A. Iwai, Y. Kageyama, and K. Kihara Glucocorticoids suppress tumor angiogenesis and in vivo growth of prostate cancer cells Clin. Cancer Res. 12 2006 3003 3009
39. K.T. Lin, Y.M. Yeh, C.M. Chuang, S.Y. Yang, J.W. Chang, S.P. Sun, and et al. Glucocorticoids mediate induction of microRNA-708 to suppress ovarian cancer metastasis through targeting Rap1B Nat. Commun. 6 2015 5917
40. C. Zhang, J. Mattern, A. Haferkamp, J. Pfitzenmaier, M. Hohenfellner, W. Rittgen, and et al. Corticosteroid-induced chemotherapy resistance in urological cancers Cancer Biol. Ther. 5 2006 59 64
41. A.M. Gorman, U.A. Hirt, S. Orrenius, and S. Ceccatelli Dexamethasone pre-treatment interferes with apoptotic death in glioma cells Neuroscience 96 2000 417 425
42. S. Benedetti, B. Pirola, P.L. Poliani, L. Cajola, B. Pollo, R. Bagnati, and et al. Dexamethasone inhibits the anti-tumor effect of interleukin 4 on rat experimental gliomas Gene Ther. 10 2003 188 192
43. M. Sui, F. Chen, Z. Chen, and W. Fan Glucocorticoids interfere with therapeutic efficacy of paclitaxel against human breast and ovarian xenograft tumors Int. J. Cancer 119 2006 712 717
44. H.P. Rutz, M. Mariotta, Doeberitz M. von Knebel, and R.O. Mirimanoff Dexamethasone-induced radioresistance occurring independent of human papilloma virus gene expression in cervical carcinoma cells Strahlenther. Onkol. 174 1998 71 74
45. M.C. Kamradt, N. Mohideen, E. Krueger, S. Walter, and A.T. Vaughan Inhibition of radiation-induced apoptosis by dexamethasone in cervical carcinoma cell lines depends upon increased HPV E6/E7 Br. J. Cancer 82 2000 1709 1716
46. C. Zhang, A. Kolb, J. Mattern, N. Gassler, T. Wenger, K. Herzer, and et al. Dexamethasone desensitizes hepatocellular and colorectal tumours toward cytotoxic therapy Cancer Lett. 242 2006 104 111
47. N. Gassler, C. Zhang, T. Wenger, P.A. Schnabel, H. Dienemann, K.M. Debatin, and et al. Dexamethasone-induced cisplatin and gemcitabine resistance in lung carcinoma samples treated ex vivo Br. J. Cancer 92 2005 1084 1088
48. A.M. Bergman, H.M. Pinedo, and G.J. Peters Steroids affect collateral sensitivity to gemcitabine of multidrug-resistant human lung cancer cells Eur. J. Pharmacol. 416 2001 19 24
49. C. Zhang, A. Kolb, P. Buchler, A.C. Cato, J. Mattern, W. Rittgen, and et al. Corticosteroid co-treatment induces resistance to chemotherapy in surgical resections, xenografts and established cell lines of pancreatic cancer BMC Cancer 6 2006 61
50. C.A. Mikosz, D.R. Brickley, M.S. Sharkey, T.W. Moran, and S.D. Conzen Glucocorticoid receptor-mediated protection from apoptosis is associated with induction of the serine/threonine survival kinase gene, sgk-1 J. Biol. Chem. 276 2001 16649 16654
51. W. Wu, S. Chaudhuri, D.R. Brickley, D. Pang, T. Karrison, and S.D. Conzen Microarray analysis reveals glucocorticoid-regulated survival genes that are associated with inhibition of apoptosis in breast epithelial cells Cancer Res. 64 2004 1757 1764
52. K. Munstedt, D. Borces, M.K. Bohlmann, M. Zygmunt, and R. von Georgi Glucocorticoid administration in antiemetic therapy: is it safe? Cancer 101 2004 1696 1702
53. D. Pan, M. Kocherginsky, and S.D. Conzen Activation of the glucocorticoid receptor is associated with poor prognosis in estrogen receptor-negative breast cancer Cancer Res. 71 2011 6360 6370
54. D. Pang, M. Kocherginsky, T. Krausz, S.Y. Kim, and S.D. Conzen Dexamethasone decreases xenograft response to Paclitaxel through inhibition of tumor cell apoptosis Cancer Biol. Ther. 5 2006 933 940
55. M.N. Skor, E.L. Wonder, M. Kocherginsky, A. Goyal, B.A. Hall, Y. Cai, and et al. Glucocorticoid receptor antagonism as a novel therapy for triple-negative breast cancer Clin. Cancer Res. 19 2013 6163 6172
56. V.K. Arora, E. Schenkein, R. Murali, S.K. Subudhi, J. Wongvipat, M.D. Balbas, and et al. Glucocorticoid receptor confers resistance to antiandrogens by bypassing androgen receptor blockade Cell 155 2013 1309 1322
57. D.J. Mangelsdorf, C. Thummel, M. Beato, P. Herrlich, G. Schutz, K. Umesono, and et al. The nuclear receptor superfamily: the second decade Cell 83 1995 835 839
58. M. Isikbay, K. Otto, S. Kregel, J. Kach, Y. Cai, D.J. Vander Griend, and et al. Glucocorticoid receptor activity contributes to resistance to androgen-targeted therapy in prostate cancer Horm Cancer 5 2014 72 89
59. J. Rainer, C. Ploner, S. Jesacher, A. Ploner, M. Eduardoff, M. Mansha, and et al. Glucocorticoid-regulated microRNAs and mirtrons in acute lymphoblastic leukemia Leukemia 23 2009 746 752
60. B.W. Han, D.D. Feng, Z.G. Li, X.Q. Luo, H. Zhang, X.J. Li, and et al. A set of miRNAs that involve in the pathways of drug resistance and leukemic stem-cell differentiation is associated with the risk of relapse and glucocorticoid response in childhood ALL Hum. Mol. Genet. 20 2011 4903 4915
61. J.K. Molitoris, K.S. McColl, and C.W. Distelhorst Glucocorticoid-mediated repression of the oncogenic microRNA cluster miR-17∼92 contributes to the induction of Bim and initiation of apoptosis Mol. Endocrinol. 25 2011 409 420
62. M. Shi, L. Du, D. Liu, L. Qian, M. Hu, M. Yu, and et al. Glucocorticoid regulation of a novel HPV-E6-p53-miR-145 pathway modulates invasion and therapy resistance of cervical cancer cells J. Pathol. 228 2012 148 157
63. H. Kawashima, T. Numakawa, E. Kumamaru, N. Adachi, H. Mizuno, M. Ninomiya, and et al. Glucocorticoid attenuates brain-derived neurotrophic factor-dependent upregulation of glutamate receptors via the suppression of microRNA-132 expression Neuroscience 165 2010 1301 1311
64. E. Vreugdenhil, C.S. Verissimo, R. Mariman, J.T. Kamphorst, J.S. Barbosa, T. Zweers, and et al. MicroRNA 18 and 124a down-regulate the glucocorticoid receptor: implications for glucocorticoid responsiveness in the brain Endocrinology 150 2009 2220 2228